血管内皮生长因子与肿瘤治疗

[1] Novel 4-anilinoquinazolines with C-7 basic side chains: design and structure activity relationship of a series of potent, orally active, VEGF receptor tyrosine kinase inhibitors. Hennequin LF, Stokes ES, Thomas AP, et al. Journal of Medicinal Chemistry . 2002

[2] Identification of a eptide blocking vascular endothelial growth factor （ VEGF ）-mediated angiogenesis. Binetruy-Tournaire R, Demangel C, Malavaud B, et al. EMBO Journal . 2000

[1] Novel 4-anilinoquinazolines with C-7 basic side chains: design and structure activity relationship of a series of potent, orally active, VEGF receptor tyrosine kinase inhibitors. Hennequin LF, Stokes ES, Thomas AP, et al. Journal of Medicinal Chemistry . 2002

[2] Identification of a eptide blocking vascular endothelial growth factor （ VEGF ）-mediated angiogenesis. Binetruy-Tournaire R, Demangel C, Malavaud B, et al. EMBO Journal . 2000